KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insulet (PODD) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to 16.66%.

  • Insulet's EBITDA Margin rose 4700.0% to 16.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.32%, marking a year-over-year increase of 19100.0%. This contributed to the annual value of 14.91% for FY2024, which is 19500.0% up from last year.
  • According to the latest figures from Q3 2025, Insulet's EBITDA Margin is 16.66%, which was up 4700.0% from 18.66% recorded in Q2 2025.
  • Insulet's EBITDA Margin's 5-year high stood at 20.87% during Q4 2023, with a 5-year trough of 8.92% in Q2 2022.
  • Its 5-year average for EBITDA Margin is 11.29%, with a median of 12.66% in 2023.
  • Per our database at Business Quant, Insulet's EBITDA Margin surged by 191200bps in 2021 and then tumbled by -189100bps in 2022.
  • Quarter analysis of 5 years shows Insulet's EBITDA Margin stood at 16.15% in 2021, then crashed by -61bps to 6.36% in 2022, then surged by 228bps to 20.87% in 2023, then decreased by -12bps to 18.29% in 2024, then dropped by -9bps to 16.66% in 2025.
  • Its last three reported values are 16.66% in Q3 2025, 18.66% for Q2 2025, and 15.61% during Q1 2025.